srd-48 Antibody

Here’s a structured FAQ for SRD-48 antibody research, combining technical specifications from available data and methodological frameworks for experimental design:

How to optimize SRD-48 antibody detection in C. elegans protein extracts?

• Methodological guidance:

  • Use Tris/PBS-based buffers (pH 8.0) with 6% trehalose for protein stabilization during extraction .

  • Validate detection via Western blot under reducing conditions (anti-His tag antibodies recommended due to N-terminal His fusion ).

  • Include controls: (i) C. elegans wild-type lysate, (ii) recombinant SRD-48 (1-316aa) at 0.1–1.0 mg/mL .

What validation strategies ensure SRD-48 antibody specificity?

• Approach:

  • Perform competitive assays with increasing concentrations of recombinant SRD-48 (UniProt ID: O17822) .

  • Use CRISPR-edited srd-48 knockout strains as negative controls.

  • Cross-test against related serpentine receptors (e.g., SRD-47) to rule out cross-reactivity.

How to address low yields in recombinant SRD-48 expression?

• Troubleshooting:

  • Expression system: Optimize E. coli induction conditions (e.g., 0.4 mM IPTG at 18°C for 16 hrs) .

  • Solubility: Test lysis buffers with 1% Triton X-100 or CHAPS.

  • Purity: Confirm >90% purity via SDS-PAGE and adjust IMAC elution gradients .

Which structural analysis techniques are suitable for SRD-48-ligand binding studies?

• Experimental design:

  • Cryo-EM: Resolve full-length SRD-48 (316aa) in liposomes to mimic membrane topology.

  • SPR/BLI: Immobilize recombinant SRD-48 (lyophilized powder, reconstituted in sterile H₂O) to quantify binding kinetics with putative ligands .

  • Molecular dynamics: Use the published AA sequence (MYGEILSFFY... ) to model transmembrane helices and ligand docking.

How to design functional assays for SRD-48 receptor-ligand interactions?

• Protocol:

  • Cell-based: Transfect HEK293T cells with SRD-48-GFP and monitor calcium flux (FLIPR assay).

  • Invertebrate models: Inject recombinant SRD-48 (50% glycerol stock) into C. elegans and quantify chemotaxis behavior.

  • Data normalization: Use β-galactosidase or luciferase reporters under SRD-48 promoter regulation.

What statistical approaches resolve contradictions in SRD-48 expression data?

• Analysis framework:

  • Apply Mann-Whitney U for non-normally distributed data (e.g., cytokine levels in Figure 4 of ).

  • Use Spearman’s correlation to link SRD-48 expression with phenotypic severity (avoid Pearson’s if data is censored) .

  • For small sample sizes, apply Fisher’s exact test to compare detection rates (e.g., IL-1B in Figure 5 of ).

Technical Specifications Table

Data Interpretation Notes

• Reproducibility: Discrepancies in SRD-48 detection may arise from lysate preparation methods (e.g., protease inhibitor cocktails).

• Antibody validation: Always include a recombinant protein control (≥90% purity, ) to distinguish false positives.

• Advanced applications: For in vivo studies, titrate reconstituted SRD-48 (0.1 mg/mL initial dose) to avoid overexpression artifacts .